Christos Sachpekidis, Olof Enqvist, Johannes Ulén, Annette Kopp‑Schneider, Leyun Pan, Elias K. Mai, Marina Hajiyianni, Maximilian Merz, Marc S. Raab, Anna Jauch, Hartmut Goldschmidt, Lars Edenbrandt, Antonia Dimitrakopoulou‑Strauss
{"title":"修正:基于人工智能的FDG PET/CT骨髓代谢活性容量评估[18F]预测多发性骨髓瘤患者的生存","authors":"Christos Sachpekidis, Olof Enqvist, Johannes Ulén, Annette Kopp‑Schneider, Leyun Pan, Elias K. Mai, Marina Hajiyianni, Maximilian Merz, Marc S. Raab, Anna Jauch, Hartmut Goldschmidt, Lars Edenbrandt, Antonia Dimitrakopoulou‑Strauss","doi":"10.1007/s00259-025-07158-6","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":"23 1","pages":""},"PeriodicalIF":7.6000,"publicationDate":"2025-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Correction to: Artificial intelligence–based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma\",\"authors\":\"Christos Sachpekidis, Olof Enqvist, Johannes Ulén, Annette Kopp‑Schneider, Leyun Pan, Elias K. Mai, Marina Hajiyianni, Maximilian Merz, Marc S. Raab, Anna Jauch, Hartmut Goldschmidt, Lars Edenbrandt, Antonia Dimitrakopoulou‑Strauss\",\"doi\":\"10.1007/s00259-025-07158-6\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11909,\"journal\":{\"name\":\"European Journal of Nuclear Medicine and Molecular Imaging\",\"volume\":\"23 1\",\"pages\":\"\"},\"PeriodicalIF\":7.6000,\"publicationDate\":\"2025-02-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Nuclear Medicine and Molecular Imaging\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00259-025-07158-6\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-025-07158-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
Correction to: Artificial intelligence–based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma
期刊介绍:
The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.